Outlook Therapeutics Eulerpool News

Outlook Therapeutics Aktie News

Outlook Therapeutics wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten Outlook Therapeutics News stellen wir hier zusammen.

• 11. Juni ·

  Yahoo
  Outlook’s wet AMD treatment accepted by SMC for NHS Scotland
• 10. Juni ·

  Yahoo
  Outlook Therapeutics® Announces SMC Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD
• 2. Juni ·

  Yahoo
  Outlook Therapeutics® Announces Commercial Launch of LYTENAVA™ (bevacizumab gamma) in Germany and the UK for the Treatment of Wet AMD
• 23. Mai ·

  Yahoo
  Outlook Therapeutics® Announces Pricing of $13.0 Million Public Offering
• 19. Februar ·

  Yahoo
  Outlook Therapeutics® Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
• 23. Januar ·

  Yahoo
  Outlook Therapeutics® Announces Presentation of Efficacy and Safety Results from NORSE EIGHT Clinical Trial Evaluating ONS-5010 for the Treatment of Wet AMD
• 16. Januar ·

  Yahoo
  Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug
• 8. Januar ·

  Yahoo
  Outlook Therapeutics® Participates in Virtual Investor “What This Means” Segment
• 30. Dezember ·

  Yahoo
  Outlook Therapeutics Stock Surges on Positive Outlook Despite Loss
• 28. Dezember ·

  Yahoo
  Outlook Therapeutics provides ONS-5010/LYTENAVA update